SCOTTSDALE, Ariz. Trumpeting a positive trend in medication adherence rates for patients, health and drug distribution giant McKesson said its medication adherence programs reached more than 6 million patients in 2009.
“More importantly, an increasing number of patients are enrolling into the company’s LoyaltyScript program and adhering more closely to prescribed therapies,” McKesson reported Thursday.
The compliance programs are offered through the company’s McKesson Patient Relationship Solutions [MPRS] division, and they point up the success the division has had in keeping patients on track with their drug therapy. “Due to higher response rates from patients and the addition of new LoyaltyScript adherence programs by manufacturers, patient adoption and utilization has increased by more than 65% over the past 12 months, and more than 300% compounded annually over the past three years. As a result, more than 28,000 patients a day are benefitting from the LoyaltyScript program,” McKesson noted.
MPRS was set up by the San Francisco-based wholesale and health services titan to improve health outcomes “by increasing patient adherence to prescribed medication regimens and awareness of pharmaceutical therapy options,” the company said. The unit’s adherence tools include a patient outreach network, integrated patient loyalty cards, call center support, automated outbound communications, in-pharmacy patient outreach programs and other services.
“McKesson’s adherence programs provide manufacturers with customized solutions to strengthen patient relationships and help patients overcome adherence challenges leading to better patient outcomes.” said Peggy Yelinek, VP/general manager, McKesson Patient Relationship Solutions. The growth of MPRS’ LoyaltyScript program, she asserted, “demonstrates that with the right services and solutions, pharmaceutical manufacturers can effectively drive brand performance and patient loyalty though improvement of patient health outcomes.”